In melanoma, the overexpression of ARG2 in Treg increases their accumulation in tissues and suppressive capacity for the inhibition of mTOR signaling by the modulation of the PI3K/AKT/mTOR signaling pathway [1,20,79]. This evidence concerns the gene MTOR and melanoma.